Empyema and parapneumonic pleural effusion. Prognostic factors about 109 patients Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers Year: 2009
Update on the management of parapneumonic pleural effusions Source: Virtual Congress 2021 – Spanish/Portuguese programme 2021 Year: 2021
Management of parapneumonic effusion and empyema in children Source: Eur Respir J 2002; 20: Suppl. 38, 589s Year: 2002
Predictors of successful pleurodesis for patients with malignant pleural effusions Source: Eur Respir J 2004; 24: Suppl. 48, 493s Year: 2004
Treatment results of patients with complicated parapneumonic effusion and empyema Source: Eur Respir J 2002; 20: Suppl. 38, 358s Year: 2002
Parapneumonic pleural effusion as a cause of hypoalbumunemia in pediatric patients Source: Eur Respir J 2006; 28: Suppl. 50, 309s Year: 2006
Late period pulmonary functions of the patients who were treated for parapneumonic effusion and empyema Source: Eur Respir J 2006; 28: Suppl. 50, 488s Year: 2006
Evaluation of patients with pleural effusions Source: Eur Respir J 2004; 24: Suppl. 48, 247s Year: 2004
Lung function in children post parapneumonic effusion and empyema Source: Eur Respir J 2002; 20: Suppl. 38, 590s Year: 2002
Procalcitonin in pleural fluid: A new tool for the diagnosis of empyema and parapneumonic pleural effusions? Source: Annual Congress 2011 - New aspects in prevention and treatment of community-acquired pneumonia and lower respiratory tract infections Year: 2011
Treatment of children with pleural effusion Source: Eur Respir J 2007; 30: Suppl. 51, 243s Year: 2007
Role of C-reactive protein in discriminating complicated and uncomplicated parapneumonic effusion from malignant and tuberculous pleural effusion Source: Virtual Congress 2021 – Clinical problems associated with cough, pleura and respiratory health status Year: 2021
Prognostic features of residual pleural thickening in parapneumonic pleural effusions Source: Eur Respir J 2003; 21: 952-955 Year: 2003
Predictive factors, microbiology and outcome of patients with parapneumonic effusion Source: Eur Respir J 2011; 38: 1173-1179 Year: 2011
Efficacy of intrapleural streptokinase use in complicated parapneumonic pleural effusions and empyema Source: Annual Congress 2008 - Pleural effusion Year: 2008
Pleural empyema in children Source: Eur Respir Monogr 2013; 61: 153-161 Year: 2013
Predictors of survival in patients with recurrent malignant pleural effusion Source: Annual Congress 2008 - Diagnostic and therapeutic approaches in pleural diseases Year: 2008
Outcomes of primary image-guided drainage of parapneumonic effusions in children Source: Eur Respir J 2002; 20: Suppl. 38, 590s Year: 2002